Ischaemic mitral regurgitation: Pathophysiology, outcomes and the conundrum of treatment

European Heart Journal

Volumn 31, Issue 24, 2010, Pages 2996-3005

  Piérard, Luc A ^a   Carabello, Blase A ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac resynchronization therapy; Echocardiography; Mitral valve; Surgery

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; NITRATE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOPPLER ECHOCARDIOGRAPHY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PERFORMANCE; HEART STRESS; HEART VENTRICLE OVERLOAD; HEART VENTRICLE WALL MOTION; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC DISEASE; CORONARY ARTERY DISEASE; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 78650343175     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq411     Document Type: Review

References (77)

1. Chaput M, Handschumacher MD, Tournoux F, Hua L, Guerrero JL, Vlahakes GJ, Levine RA. Mitral leaflet adaptation to ventricular remodelling occurrence and adequacy in patients with functional mitral regurgitation. Circulation 2008;118: 845-852.
2. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 2005;112:745-758.
3. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen ST, Westo SA, Meverden RA, Roger VL. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005;111:295-301. (Pubitemid 40165335)
4. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersh BJ, Basta C, Moye L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation 1997;96:827-833.
5. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 1997;96:1826-1834.
6. Yiu S, Enriquez-Sarano M, Tribouilloy C, Seward J, Tajik A. Determination of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000;102:1400-1406.
7. Messas E, Guerrero JL, Handschumacher MD, Conrad C, Chow CM, Sullivan S, Yoganathan AP, Levine RA. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001;104:1958-1963.
8. Watanabe N, Ogasawara Y, Yamaura Y, Kawamoto T, Toyota E, Akasaka T, Yoshida K. Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol 2005;45:763-769.
9. Messas E, Guerrero JL, Handschumacher MD, Chow CM, Sullivan J, Schwammenthal E, Levine AR. Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional and contrast echocardiography with strain rate measurement. Circulation 2001;104:1952-1957.
10. Radermecker MA, Lancellotti P. The mechanisms of chronic ischemic mitral regurgitation. Ann Thorac Surg 2007;83:1918-1925.
11. Bursi F, Enriquez-Sarano M, Jacobsen SJ, Roger VL. Mitral regurgitation after myo-cardial infarction: a review. Am J Med 2006;119:103-112.
12. Carabello BA. Ischemic mitral regurgitation and ventricular remodelling. J Am Coll Cardiol 2004;43:384-385.
13. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH. Dynamic aspects of acute regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 1979;60:170-176.
14. Olson L, Subramanian R, Ackermann D, Orszulak T, Edwards W. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 1987;62:22-24.
15. Yellin E, Yoran C, Sonnenblick E, Gabbay S, Frater R. Dynamic changes in the canine mitral regurgitant orifice area during ventricular ejection. Circ Res 1979; 45:677-683.
16. Schwammenthal E, Chen C, Benning F, Block F, Breithardt G, Levine R. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation 1994; 90:307-322.
17. Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 1998;32: 1819-1824.
18. Lebrun F, Lancellotti P, Piérard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 2001;38: 1685-1692.
19. Lancellotti P, Lebrun F, Piérard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2003;42:1921-1928. (Pubitemid 37485566)
20. Lancellotti P, Piérard LA. Chronic ischaemic mitral regurgitation: exercise testing reveals its dynamic component. Eur Heart J 2005;26:1816-1817.
21. Desjardin VA, Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB. Intensity of murmurs correlates with severity of valvular regurgitation. Eur Heart J 1196; 100:149-156.
22. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin J-L, Badano L, Zamorano JL. European Association of Echo-cardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11:307-332.
23. Hall SA, Brickner E, Willett DL, Irani WN, Afridi A, Grayburn PA. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena con-tracta. Circulation 1997;95:636-642.
24. Little SH, Pirat B, Kumar R, Igo SR, McCulloch M, Hartley CJ, Xu J, Zoghbi WA. Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. J Am Coll Cardiol Img 2008;1:695-704.
25. Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ, Krohn MJ, Mays JM. Quantitative Doppler assessment of valvular regurgitation. Circulation 1993;87:841-848.
26. Enriquez-Sarano M, Seward JB, Bailey KR, Tajik AJ. Effective regurgitant orifice area: a non-invasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol 1994;23:443-451.
27. Enriquez-Sarano M, Fletcher AM, Hayes SN, Bailey KR. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 1995;25:703-709.
28. Song JM, Kim MJ, Kim YJ, Kang SH, Kim JJ, Kang DH, Song JK. Three-dimensional characteristics of functional mitral regurgitation in patients with severe left ventricular dysfunction: a real-time three-dimensional colour Doppler echocardiogra-phy study. Heart 2008;94:590-596.
29. Yosefy C, Levine RA, Solis J, Vaturi M, Handschumacher MD, Hung J. Proximal flow convergence region as assessed by real-time 3-dimensional echocardiogra-phy: challenging the hemispheric assumption. J Am Soc Echocardiogr 2007;20: 389-396.
30. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regur-gitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-1764.
31. Himelman RB, Stulbarg M, Kircher B, Lee E, Kee L, Dean NC, Golden J, Wolfe CL, Schiller NB. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989;79:863-871. (Pubitemid 19100546)
32. Lancellotti P, Stainier PY, Lebois F, Piérard L. Effect of dynamic left ventricular dys-synchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am J Cardiol 2005;96:1304-1307.
33. Lehmann KG, Francis CK, Dodge HT, the TIMI Study Group. Mitral regurgitation in the early myocardial infarction. Ann Intern Med 1992;117:10-17.
34. Tcheng JE, Jackman JD, Nelson CL, Gardner LH, Smith LR, Rankin JS, Califf RM, Stack RS. Outcome of patients sustaining acute ischaemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992;117:18-24.
35. Feinberg MS, Schwammenthal E, Shlizerman L, Porter A, Hod H, Freimark D, Matezky S, Boyko V, Mandelzweig L, Vered Z, Behar S, Sagie A. Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol 2000;86:903-907.
36. Perez de Isla L, Zamorano J, Quezada M, Almeria C, Rodrigo JL, Serra V, Rubira JCG, Ortiz AF, Macaya C. Prognostic significance of functional mitral regur-gitation after a first non-ST-segment elevation acute coronary syndrome. Eur Heart J 2006;27:2655-2660.
37. Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005;26: 1528-1532.
38. Lancellotti P, Kulbertus HE, Piérard LA. Predictors of rapid QRS widening in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 2004;93:1410-1412.
39. Ennezat PV, Maréchaux S, Huerre C, Deklunder G, Asseman P, Jude B, Van Belle E, Mouquet F, Bauters C, Lamblin N, LeJemtel TH, de Groote P. Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J 2008;155:752-757.
40. Piérard LA, Lancellotti P. The role of ischemic mitral regurgitation in the patho-genesis of acute pulmonary edema. N Engl J Med 2004;35:871-873.
41. Piérard LA, Lancellotti P. Dyspnea and stress testing. New Engl J Med 2006;354: 871-873.
42. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol 2008; 52:319-326.
43. Lancellotti P, Marwick T, Piérard LA. Valvular heart disease: how to manage ischaemic mitral regurgitation. Heart 2008;94:1497-1502.
44. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponitowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-2442.
45. Capomolla S, Febo O, Gnemmi M, Roccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F. Betablockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000;139:596-608.
46. Task Force Members, Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano U, Filippatos G, Hellemans I, Krestensen SD, McGregor K, Sechtem U, Silbert S, Tendera M, Widimsky P, Zamorano JL, Priori SG, Blomström-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GYH, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-2295.
47. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C. An integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. J Am Coll Cardiol 2003;41: 765-770.
48. Porciani MC, Macioce R, Demarchi G, Chiostri M, Musili N, Capelli F, Lilli A, Ricciardi G, Padeletti L. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr 2006;7:31-39.
49. Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1619-1625.
50. Brandt RR, Reiner C, Arnold R, Sperzel J, Pitschner HF, Hamm W. Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy. Eur Heart J 2006;27:187-192.
51. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ. Acute effects of initiation and withdrawal of cardiac resynchro-nization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007;50:2071-2077.
52. Lancellotti P, Mélon P, Sakalihasan N, Waleffe A, Dubois C, Bertholet M, Piérard LA. Effect of cardiac resynchronization therapy on functional mitral regur-gitation in heart failure. Am J Cardiol 2004;94:1462-1465.
53. Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M, Verstreken S, Geelen P, Penicka M, De Bruyne B, Barunek J. Early and late effects of cardiac resynchronization therapy on exercise induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur Heart J 2007;28:2134-2141.
54. Aklog L, Filsoufi F, Flores KQ, Chen RH, Cohn LH, Nathan NS, Byrne JG, Adams DH. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104(Suppl. I): I-8-I-75.
55. Schroder JN, Willliams ML, Hata JA, Muhlbaier LH, Swaminathan M, Matheuw JP, Glower DD, O'Connor CM. Impact of mitral valve regurgitation evaluated by intraoperative tranoesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. Circulation 2005;112(Suppl. I): I-293-I-298.
56. Bolling SJ, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. Thorac Cardiovasc Surg 1998;115:381-388.
57. Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MIM, Boersma E, Schalij MJ, van der Wall EE, Dion RA. Restrictive annuloplasty and coronary revas-cularization in ischemic mitral regurgitation. Results in reverse left ventricular remodeling. Circulation 2004;110: II-103-II-108.
58. Wu AU, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-387.
59. Wong DR, Agnihotri AK, Hung JW, Vlahakes GJ, Akins CW, Hilgenberg AD, Madsen JC, MacGillivray TE, Picard MH, Torchiana DF. Long-term survival after surgical revascularization for moderate ischemic mitral regurgitation. Ann Thorac Surg 2005;80:570-577.
60. Diodato MD, Moon MR, Pasque MK, Barner HB, Moazami N, Lawton JS, Bailey MS, Guthrie TJ, Meyers BF, Damiano RJ Jr. Repair of ischemic mitral regur-gitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg 2004;78:794-799.
61. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, Blackstone EH, Lytle BW. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic regurgitation. J Am Coll Cardiol 2007;49:2191-2201.
62. Fattouch K, Guccione F, Sampognaro S, Panzarella G, Corrado E, Navarra E, Calvaruso D, Ruvolo G. POINT: Efficacty of adding mitral valve restrictive annu-loplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg 2009;138: 278-285.
63. Jones HR. Adding mitral valve annuloplasty to surgical revascularization does not benefit patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;22:2202-2203.
64. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease. The Task Force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268.
65. Gisbert A, Soulière V, Denault AY, Bouchard D, Couture P, Pellerin M, Carrier M, Levesque S, Ducharme A, Basmadjian AJ. Dynamic quantitative echocardiographic evaluation of mitral regurgitation in the operating department. J Am Soc Echocar-diog 2006;19:140-146.
66. Gelsomino S, Lorusso R, De Cicco G, Capecchi I, Rostagno C, Caciolli S, Romagnoli S, Da Broi U, Stefàno P, Gensini GF. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J 2008;29: 231-240.
67. McGee EC Jr, Gillinov M, Blackstone EH, Rajeswaran J, Cohen G, Najam F, Shiota T, Sabik JF, Lytle BW, McCarthy PM, Cosgrove DM. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004;128:916-924.
68. Hung J, Papakostas L, Tahta SA, Hardy BG, Bollen BA, Duran CM, Levine RA. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty. Circulation 2004;110(Suppl. II): II85-II90.
69. Crabtree TD, Bailey MS, Moon MR, Munfakh N, Pasque MK, Lawton JS, Moazami N, Aubuchon KA, Al-Dadah AS, Damiano RJ Jr. Recurrent mitral regur-gitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg 2008;85:1537-1543.
70. Magne J, Sénéchal M, Mathieu P, Dumesnil G, Dagenais F, Pibarot P. Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008;51:1692-1701.
71. Magne J, Pibarot Ph, Dagenais F, Hachicha Z, Dumesnil JG, Sénéchal M. Preopera-tive posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation 2007;115: 787-791.
72. Magne J, Girerd N, Sénéchal M, Mathieu P, Dagenais F, Dumesnil JG, Charbonneau E, Voisine P, Pibarot P. Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation 2009;120(suppl.): S104-S111.
73. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regur-gitation. Eur J Cardiothorac Surg 2010, doi:10.1016/j.ejcts.2010.06.034. Published online ahead of print 18 August 2010.
74. De Bonis M, Lapenna E, La Canna G, Ficarra E, Pagliaro M, Torracca L, Maisano F, Alfieri O. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the 'edge-to-edge' technique. Circulation 2005;112: I402-I408.
75. Webb JG, Hamek J, Munt BI, Kimblad PO, Chandavimol M, Thompson CR, Mayo JR, Solem JO. Percutaneous transvenous mitral annuloplasty. Initial human experience with device implantation in the coronary sinus. Circulation 2006;113: 851-855.
76. Sack S, Kahlert P, Bilodeau L, Piérard LA, Lancellotti P, Legrand V, Bartunek J, Vanderheyden M, Hoffmann R, Schauerte P, Shiota T, Marks DS, Erbel R, Ellis SG. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Interv 2009;2:277-284.
77. Messas E, Bel A, Morichetti M, Carrion C, Handschumacher MD, Peyrard S, Vilquin JT, Desnos M, Bruneval P, Carpentier A, Menasché P, Levine RA, Hagège AA. Autologous myoblast transplantation for chronic ischemic mitral regurgitation. J Am Coll Cardiol 2006;47:2086-2093.